Similar sputum secretory leykocyte inhibitor and Clara cell protein 16 levels between current and ex-smokers with COPD Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008
Clara cell protein (CC16) in serum and urine after exercise challenge Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012
Clara cell specific protein (CC16) after LPS inhalation in healthy subjects Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside Year: 2003
Clara cell secretory protein (CC16) and surfactant protein D (SPD) in sputum supernatant in severe refractory asthma (SRA) Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012
Serum Clara cell protein is reduced in newborn cord blood of heavy smoking mothers Source: Eur Respir J 2004; 24: Suppl. 48, 27s Year: 2004
Clara cell secretory protein and its mRNA expression in induced sputum of acute bacterial exacerbations of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 543s Year: 2002
Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects Source: Eur Respir J 2002; 20: 1152-1161 Year: 2002
Clara cell protein (CC16) as a biomarker for ozone exposure in humans Source: Eur Respir J 2002; 20: Suppl. 38, 569s Year: 2002
Swimmers have evidence of epithelial dysfunction measured as increased urinary concentration of Clara cell protein (CC16) after swim exercise Source: Annual Congress 2009 - Novel insights in exercise physiology from cells to humans Year: 2009
Measuring bronchial responsiveness in 6 and 7 year olds Source: Annual Congress 2008 - Early life risk factors for childhood asthma: evidence from birth cohort studies II Year: 2008
Serum Clara cell protein (CC16), a marker of the integrity of the air-blood barrier in sarcoidosis Source: Eur Respir J 2001; 18: 507-514 Year: 2001
Biomarkers of early respiratory effects in smoking adolescents Source: Eur Respir J 2011; 38: 1287-1293 Year: 2011
The effect of occupational exposure to glutaraldehyde on serum Clara cell protein Source: Eur Respir J 2002; 20: Suppl. 38, 603s Year: 2002
Adenosine receptor expression in sputum of COPD and asymptomatic smokers, before and one year after smoking cessation Source: Eur Respir J 2007; 30: Suppl. 51, 213s Year: 2007
Association between serum clara cell secretory protein (CC-16) levels and asthma-related phenotypes among adults from the EGEA study Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012
Neutrophil predominance phenotype in bronchial asthma. Therapeutic implication and the role of Clara cell 16-kD protein Source: Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation Year: 2007
Diurnal variation in the serum levels of Clara cell protein (CC16) in humans Source: Eur Respir J 2003; 22: Suppl. 45, 75s Year: 2003
Phosphodiesterase 4 and 5 inhibitors decrease HO-1 and IL-8 gene expression induced by cigarette smoke Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008
Increased numbers of airway wall plasma cells in smokers with chronic bronchitis: co-localization and gene expression for interleukin 4 and 5 Source: Eur Respir J 2002; 20: Suppl. 38, 378s Year: 2002
Osteopontin expression is increased in serum, BAL and bronchial tissue of asymptomatic smokers Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009